These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38634701)

  • 1. Pharmacokinetics of Tranexamic Acid (TXA) Delivered by Expeditious Routes in a Swine Model of Polytrauma and Hemorrhagic Shock.
    Wilson M; Stuart S; Lassiter B; Parker T; Martin C; Healy R; Treager C; Sulava E; Gower L; Fernandez P; Friedrich E
    Prehosp Emerg Care; 2024; 28(5):680-688. PubMed ID: 38634701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Tranexamic Acid Given as an Intramuscular Injection Compared to Intravenous Infusion in a Swine Model of Ongoing Hemorrhage.
    Spruce MW; Beyer CA; Caples CM; DeSoucy ES; Kashtan HW; Hoareau GL; Grayson JK; Johnson MA
    Shock; 2020 Jun; 53(6):754-760. PubMed ID: 31389905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Tranexamic Acid via Intravenous, Intraosseous, and Intramuscular Routes in a Porcine (Sus scrofa) Hemorrhagic Shock Model.
    DeSoucy ES; Davidson AJ; Hoareau GL; Simon MA; Tibbits EM; Ferencz SE; Grayson JK; Galante JM
    J Spec Oper Med; 2019; 19(4):80-84. PubMed ID: 31910476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No intravenous access, no problem: Intraosseous administration of tranexamic acid is as effective as intravenous in a porcine hemorrhage model.
    Lallemand MS; Moe DM; McClellan JM; Loughren M; Marko S; Eckert MJ; Martin MJ
    J Trauma Acute Care Surg; 2018 Feb; 84(2):379-385. PubMed ID: 29194320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular administration of tranexamic acid in a large swine model of hemorrhage with hyperfibrinolysis.
    Haberkorn CJ; Severance CC; Wetmore NC; West WG; Ng PC; Cendali F; Pitotti C; Schauer SG; Maddry JK; Bebarta VS; Hendry-Hofer TB
    J Trauma Acute Care Surg; 2024 May; 96(5):735-741. PubMed ID: 37962201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of hemorrhage on the pharmacokinetics of tranexamic acid in a swine model.
    Derickson MJ; McClellan JM; Marko ST; Kuckelman JP; Phillips CJ; Barron MR; Martin MJ; Loughren MJ
    J Trauma Acute Care Surg; 2018 Jul; 85(1S Suppl 2):S44-S48. PubMed ID: 29953031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular Tranexamic Acid in Tactical and Combat Settings.
    Vu EN; Wan WCY; Yeung TC; Callaway DW
    J Spec Oper Med; 2018; 18(1):62-68. PubMed ID: 29533435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOW SHOULD TRANEXAMIC ACID BE ADMINISTERED IN HEMORRHAGIC SHOCK? CONTINUOUS SERUM CONCENTRATION MEASUREMENTS IN A SWINE MODEL.
    Lynghaug T; Bakke HK; Fuskevåg OM; Nielsen EW; Dietrichs ES
    Shock; 2023 Nov; 60(5):707-712. PubMed ID: 37695638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial.
    Grassin-Delyle S; Shakur-Still H; Picetti R; Frimley L; Jarman H; Davenport R; McGuinness W; Moss P; Pott J; Tai N; Lamy E; Urien S; Prowse D; Thayne A; Gilliam C; Pynn H; Roberts I
    Br J Anaesth; 2021 Jan; 126(1):201-209. PubMed ID: 33010927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular uptake of tranexamic acid during haemorrhagic shock in a swine model.
    Bakke HK; Fuskevåg OM; Nielsen EW; Dietrichs ES
    Scand J Trauma Resusc Emerg Med; 2021 Dec; 29(1):171. PubMed ID: 34922577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tranexamic acid plasma concentrations when administered via intraosseous and intravenous routes.
    Boysen SR; Pang JM; Mikler JR; Knight CG; Semple HA; Caulkett NA
    Am J Emerg Med; 2017 Feb; 35(2):227-233. PubMed ID: 27816438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage.
    Wu X; Benov A; Darlington DN; Keesee JD; Liu B; Cap AP
    PLoS One; 2019; 14(10):e0223406. PubMed ID: 31581265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.
    Grassin-Delyle S; Semeraro M; Lamy E; Urien S; Runge I; Foissac F; Bouazza N; Treluyer JM; Arribas M; Roberts I; Shakur-Still H
    Br J Anaesth; 2022 Mar; 128(3):465-472. PubMed ID: 34998508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic Acid in Civilian Trauma Care in the California Prehospital Antifibrinolytic Therapy Study.
    Neeki MM; Dong F; Toy J; Vaezazizi R; Powell J; Wong D; Mousselli M; Rabiei M; Jabourian A; Niknafs N; Burgett-Moreno M; Vara R; Kissel S; Luo-Owen X; O'Bosky KR; Ludi D; Sporer K; Pennington T; Lee T; Borger R; Kwong E
    West J Emerg Med; 2018 Nov; 19(6):977-986. PubMed ID: 30429930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid corrects fibrinolysis in the presence of acidemia in a swine model of severe ischemic reperfusion.
    DeBarros M; Hatch Q; Porta CR; Salgar S; Izenberg S; DuBose J; Eckert M; Martin M
    J Trauma Acute Care Surg; 2014 Mar; 76(3):625-32; discussion 632-3. PubMed ID: 24553528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.
    Kane Z; Picetti R; Wilby A; Standing JF; Grassin-Delyle S; Roberts I; Shakur-Still H
    Eur J Pharm Sci; 2021 Sep; 164():105893. PubMed ID: 34087356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta-analysis of pharmacokinetic studies in healthy volunteers.
    Grassin-Delyle S; Semeraro M; Foissac F; Bouazza N; Shakur-Still H; Roberts I; Treluyer JM; Urien S
    Fundam Clin Pharmacol; 2019 Dec; 33(6):670-678. PubMed ID: 31013357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience.
    Lipsky AM; Abramovich A; Nadler R; Feinstein U; Shaked G; Kreiss Y; Glassberg E
    Injury; 2014 Jan; 45(1):66-70. PubMed ID: 24074828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Topical and Intravenous Tranexamic Acid for Total Knee Replacement: A Randomized Double-Blinded Controlled Study of Effects on Tranexamic Acid Levels and Thrombogenic and Inflammatory Marker Levels.
    Jules-Elysee KM; Tseng A; Sculco TP; Baaklini LR; McLawhorn AS; Pickard AJ; Qin W; Cross JR; Su EP; Fields KG; Mayman DJ
    J Bone Joint Surg Am; 2019 Dec; 101(23):2120-2128. PubMed ID: 31800425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prehospital tranexamic acid on outcome in polytrauma patients with associated severe brain injury.
    van Wessem KJP; Jochems D; Leenen LPH
    Eur J Trauma Emerg Surg; 2022 Jun; 48(3):1589-1599. PubMed ID: 34775510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.